Defirix News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Defirix. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Defirix Today - Breaking & Trending Today

Hansa Biopharma AB: Hansa Biopharma announces positive reimbursement decision for Idefirix (imlifidase) in Belgium as desensitization treatment for highly sensitized patients in kidney transplantation

LUND, Sweden, June 1, 2023 /PRNewswire/ Hansa Biopharma, "Hansa" (Nasdaq Stockholm: HNSA), a pioneer in enzyme technology for rare immunological conditions, today announced that it has attained ....

Region Flamande , Stephanie Kenney , Hansa Biopharma , Prnewswire Hansa Biopharma , Dirk Kuypers , Klaus Sindahl , Department Of Nephrology , University Hospitals Leuven , European Union , European Medicines Agency Ema Priority , Renal Transplantation Program , Vp Global Corporate Affairs , European Medicines Agency , Nasdaq Stockholm , Human Leukocyte Antigens , Product Characteristics , End Stage Renal Disease , Dial Transplant , Englj Med ,

Hansa Biopharma announces positive reimbursement decision for Idefirix in Czech Republic | Health

Hansa Biopharma announces that it has attained reimbursement in the Czech Republic for its first-in-class treatment, Idefirix, for the desensitization treatment of highly sensitized adult patients prior to kidney transplant from a deceased donor. ....

Czech Republic , Hansa Biopharma , Hansa Biopharma Announces That It Has Attained Reimbursement In The Czech Republic For Its First Class Treatment , Or The Desensitization Treatment Of Highly Sensitized Adult Patients Prior To Kidney Transplant Froma Deceased Donor ,